• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙瓦伦西亚拉利贝拉卫生局关于 SARS-CoV-2 再感染的回顾性横断面观察性研究。

A retrospective cross-sectional observational study of SARS-CoV-2 reinfection in La Ribera Health Department, Valencia, Spain.

机构信息

Internal Medicine Department, La Ribera University Hospital, Alzira, Valencia, Spain.

Servicio de Medicina Interna, Hospital Universitario de La Ribera, Alzira, Valencia, Spain.

出版信息

J Med Microbiol. 2022 Oct;71(10). doi: 10.1099/jmm.0.001599.

DOI:10.1099/jmm.0.001599
PMID:36301607
Abstract

. The possibility of reinfection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a widely proven fact and may have clinical implications.. It is not known whether there have been cases of reinfection by SARS-CoV-2 in La Ribera Health Department. To determine whether there have been cases of reinfection by SARS-CoV-2 in La Ribera Health Department and to identify their characteristics.. Retrospective cross-sectional observational study of cases of reinfection by SARS-CoV-2 in the population of La Ribera Department between March 2020 and February 2021. The positive baseline cohort includes all cases positive by RT-PCR for SARS-CoV-2, with reinfection cases being those that, after resolution of the first episode according to the World Health Organization (WHO) criteria, presented a new positive RT-PCR result.. Out of a total of 15 687 cases with positive RT-PCR, 40 were considered to be reinfections, which meant a cumulative incidence of 0.255 % and an incidence density of 5.05 cases per 100 000 person-days. Most of the cases occurred during the highest incidence peaks of the pandemic in the department. Seventy-five per cent of the patients in these cases were older than 40 years, 42.5 % were healthcare professionals or nursing home residents and 12.5 % had an immunosuppressive comorbidity. There were no severe, critical or death cases. In the reinfection episodes, with respect to the first episode, there was a tendency to be milder, they required fewer days of hospitalization, their RT-PCR became negative earlier, they developed a greater humoral response and the sick leave period was shorter. The median period between the RT-PCR in the first episode and the RT-PCR in the second episode was 127.5 days (range: 48-301; IQR: 89.5-256.25). SARS-CoV-2 reinfection cases are rare, tend to be mild and can occur within a median period of 127.5 days.

摘要

. 严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 再次感染的可能性是一个已被广泛证实的事实,并且可能具有临床意义。. 目前尚不清楚拉·里贝拉卫生局是否有 SARS-CoV-2 再次感染病例。. 目的 确定拉·里贝拉卫生局是否有 SARS-CoV-2 再次感染病例,并确定其特征。. 这是一项对 2020 年 3 月至 2021 年 2 月期间拉·里贝拉卫生局人群中 SARS-CoV-2 再次感染病例的回顾性横断面观察性研究。基线阳性队列包括所有通过 RT-PCR 检测 SARS-CoV-2 呈阳性的病例,再感染病例是指根据世界卫生组织 (WHO) 标准首次发作缓解后,新出现 RT-PCR 阳性结果的病例。. 在总共 15687 例 RT-PCR 阳性病例中,有 40 例被认为是再感染,这意味着累计发病率为 0.255%,发病率密度为每 100000 人-日 5.05 例。大多数病例发生在该部门大流行期间发病率最高的高峰期。这些病例中有 75%的患者年龄大于 40 岁,42.5%为医护人员或疗养院居民,12.5%有免疫抑制合并症。没有严重、危急或死亡病例。在再感染发作中,与首次发作相比,病情趋于较轻,住院天数较少,RT-PCR 更早转为阴性,产生更大的体液反应,病假时间较短。首次 RT-PCR 与第二次 RT-PCR 之间的中位时间为 127.5 天(范围:48-301;IQR:89.5-256.25)。SARS-CoV-2 再感染病例罕见,倾向于轻症,可在 127.5 天的中位时间内发生。

相似文献

1
A retrospective cross-sectional observational study of SARS-CoV-2 reinfection in La Ribera Health Department, Valencia, Spain.西班牙瓦伦西亚拉利贝拉卫生局关于 SARS-CoV-2 再感染的回顾性横断面观察性研究。
J Med Microbiol. 2022 Oct;71(10). doi: 10.1099/jmm.0.001599.
2
Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.2020 年 3 月至 2022 年 7 月塞尔维亚儿童和青少年中 SARS-CoV-2 再感染的发生率、风险和严重程度。
JAMA Netw Open. 2023 Feb 1;6(2):e2255779. doi: 10.1001/jamanetworkopen.2022.55779.
3
SARS-CoV-2 reinfection and COVID-19 severity.SARS-CoV-2 再感染与 COVID-19 严重程度。
Emerg Microbes Infect. 2022 Dec;11(1):894-901. doi: 10.1080/22221751.2022.2052358.
4
Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.首次感染 SARS-CoV-2 对再次感染的保护作用:使用英格兰聚合酶链反应(PCR)检测数据的匹配回顾性队列研究。
Epidemiol Infect. 2022 May 24;150:e109. doi: 10.1017/S0950268822000966.
5
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait.科威特儿科队列中 SARS-CoV-2 再感染的发生率。
BMJ Open. 2022 Jun 28;12(6):e056371. doi: 10.1136/bmjopen-2021-056371.
6
Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.COVID-19 大流行期间医护人员 2 年以上的再感染率。
Sci Rep. 2023 Jan 13;13(1):712. doi: 10.1038/s41598-022-25908-6.
7
Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk.有症状的 SARS-CoV-2 再感染:医护人员和免疫抑制个体为高危人群。
BMC Infect Dis. 2021 Sep 6;21(1):923. doi: 10.1186/s12879-021-06643-1.
8
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.自然感染后新型 SARS-CoV-2 变体再感染:英国 13 家养老院的前瞻性观察队列研究。
Lancet Healthy Longev. 2021 Dec;2(12):e811-e819. doi: 10.1016/S2666-7568(21)00253-1. Epub 2021 Dec 1.
9
Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.西班牙早期涉及相同或不同基因组谱系的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2023 Jun;29(6):1154-1161. doi: 10.3201/eid2906.221696. Epub 2023 May 2.
10
Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait.科威特成年人中 SARS-CoV-2 再感染率的全国性研究。
East Mediterr Health J. 2023 Feb 26;29(2):146-150. doi: 10.26719/emhj.23.015.

引用本文的文献

1
SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease.严重急性呼吸综合征冠状病毒2型再感染:给动脉粥样硬化性心血管疾病患者本就功能失调的内皮增加损伤。
Atheroscler Plus. 2023 Sep;53:1-5. doi: 10.1016/j.athplu.2023.06.002. Epub 2023 Jun 2.